Elda Tagliabue

Head of Molecular Targeting Unit

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Elda Tagliabue is the Head of the Molecular Targeting Unit at Fondazione IRCCS Istituto Nazionale dei Tumori in Italy. Her research primarily focuses on breast cancer progression, the role of the microbiota, and the intricate interactions within the tumor microenvironment. Recent publications include studies on macrophage behavior in cancer and the potential of circulating miRNAs as biomarkers for early diagnosis.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (17)

Lucia Sfondrini

Associate Professor In General Pathology and Immunology

University of Milan

ITALY

Elda Tagliabue

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The Emerging Role of the Microbiota in Breast Cancer Progression

ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation

Live or Heat-Killed <i>Lactobacillus rhamnosus </i>Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model

The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective

The Educational Program of Macrophages toward a Hyperprogressive Disease-Related Phenotype Is Orchestrated by Tumor-Derived Extracellular Vesicles

HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer

Worldwide SARS-CoV-2 haplotype distribution in early pandemic

Circulating mirnas as novel non‐invasive biomarkers to aid the early diagnosis of suspicious breast lesions for which biopsy is recommended

Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay

Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain

Collaborators (17)

Lucia Sfondrini

Simone Guglielmetti

Tiziana Triulzi

Daniele Lecis

Marta Giussani

Milena Perrone

Giulia Cosentino

Mariangela Figini

NICOLETTA GAGLIANO

loris de cecco

MARTINA DI MODICA

Serenella Pupa

Michele Sommariva

Serena Di Cosimo

Mario Paolo Colombo

Federico Ambrogi

Andrea Mariancini

Make your next move.